UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000012263
Receipt No. R000014333
Scientific Title A Multinational, Randomized, Phase III Study of XELIRI with/without Bevacizumab versus FOLFIRI with/without Bevacizumab as Second-line Therapy in Patients with Metastatic Colorectal Cancer.
Date of disclosure of the study information 2013/11/11
Last modified on 2019/02/22 13:33:58

No. Disposal Last modified on Item of update
1 Insert 2013/11/11 14:12:06
2 Update 2013/12/12 12:22:10 Recruitment status
3 Update 2014/03/14 17:24:56 Institutions
4 Update 2015/05/12 14:56:42 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Address
Address
TEL
Email
Institutions
5 Update 2015/05/12 16:12:04 Email
6 Update 2016/02/02 16:02:43 Recruitment status
Last follow-up date
7 Update 2019/02/22 13:33:58 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
URL related to results and publications


Contact us.